Press Releases

2017  |  2016  |  2015  |  2014  |  2013

BD to Present at Investor Healthcare Conferences

BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting

BD Announces Offerings of $2.25 Billion of Common Stock and $2.25 Billion of Depositary Shares Representing Interests in Mandatory Convertible Preferred Stock

BD Announces Commencement of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes

BD to Invest $60 Million in Nebraska Manufacturing Facility

BD Announces Results for 2017 Second Fiscal Quarter

BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering

BD Licenses Novel Molecular Indexing Technology to Roche

BD Announces Appointment of Tom Polen as President

BD to Acquire Bard for $24 Billion

BD Receives FDA 510(k) Clearance for New Flow Cytometer System with Leucocount Reagent Assay

BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call

BD Completes Acquisition of Caesarea Medical Electronics

BD Launches "Power in Prevention" Program to Help Minimize Risk of Infections during Surgical Process at 2017 AORN Annual Conference

BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management

BD Launches New IV Medication Safety Solution, Helping Improve Patient Safety

Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests

BD Partnership Honored by U.S. Chamber of Commerce Foundation at the Health Means Business National Summit with Healthy10 Award

BD Demonstrates Synchronized Technology Platform at HIMSS17

BD to Present at Investor Healthcare Conferences

BD Initiates New Industry Alliance To Combat Rising Opioid Crisis

BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform

BD Announces Results for 2017 First Fiscal Quarter

New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes Through Collaboration

BD Board Declares Dividend

PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions

Global Stakeholders Join Forces in the Fight Against Antimicrobial Resistance

BD Announces Webcast of Annual Meeting of Shareholders

BD Launches Reagents to Simplify Single Cell Research

Clarivate Analytics Names 2016 Top 100 Global Innovators

BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call